CVS Corp (CVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 953,000 | 5,319,000 | 3,612,000 | 2,071,000 | 1,147,000 |
| Depreciation Amortization | 619,000 | 2,475,000 | 1,847,000 | 1,236,000 | 617,000 |
| Income taxes - deferred | 14,000 | 18,000 | 119,000 | 75,000 | 17,000 |
| Accounts receivable | 48,000 | -243,000 | -1,714,000 | -1,279,000 | -1,131,000 |
| Accounts payable and accrued liabilities | -539,000 | 2,189,000 | 1,570,000 | 1,164,000 | 798,000 |
| Other Working Capital | 1,892,000 | 1,329,000 | 1,633,000 | 55,000 | 601,000 |
| Other Operating Activity | 546,000 | -946,000 | 953,000 | 764,000 | 390,000 |
| Operating Cash Flow | $3,533,000 | $10,141,000 | $8,020,000 | $4,086,000 | $2,439,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,000 | -80,000 | -40,000 | 28,000 | 14,000 |
| PPE Investments | -452,000 | -2,224,000 | -1,585,000 | -1,091,000 | -596,000 |
| Net Acquisitions | -93,000 | -524,000 | -333,000 | -168,000 | -51,000 |
| Sale Of Investment | N/A | 91,000 | 76,000 | N/A | N/A |
| Other Investing Activity | 0 | 267,000 | 230,000 | 0 | 0 |
| Investing Cash Flow | $-537,000 | $-2,470,000 | $-1,652,000 | $-1,231,000 | $-633,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 1,874,000 | 340,000 | 745,000 | N/A |
| Debt Issued | 0 | 3,455,000 | 3,455,000 | 3,455,000 | N/A |
| Debt Repayment | 0 | -5,943,000 | -5,185,000 | -3,579,000 | N/A |
| Common Stock Issued | 121,000 | 296,000 | 277,000 | 193,000 | 104,000 |
| Common Stock Repurchased | -3,621,000 | -4,461,000 | -4,000,000 | -3,960,000 | -2,066,000 |
| Dividend Paid | -516,000 | -1,840,000 | -1,384,000 | -929,000 | -470,000 |
| Other Financing Activity | -117,000 | -142,000 | -143,000 | -114,000 | -55,000 |
| Financing Cash Flow | $-4,133,000 | $-6,761,000 | $-6,640,000 | $-4,189,000 | $-2,487,000 |
| Exchange Rate Effect | N/A | 2,000 | 2,000 | 2,000 | 1,000 |
| Beginning Cash Position | 3,520,000 | 2,608,000 | 2,459,000 | 2,459,000 | 2,459,000 |
| End Cash Position | 2,383,000 | 3,520,000 | 2,189,000 | 1,127,000 | 1,779,000 |
| Net Cash Flow | $-1,137,000 | $912,000 | $-270,000 | $-1,332,000 | $-680,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,533,000 | 10,141,000 | 8,020,000 | 4,086,000 | 2,439,000 |
| Capital Expenditure | -457,000 | -2,224,000 | -1,607,000 | -1,102,000 | -598,000 |
| Free Cash Flow | 3,076,000 | 7,917,000 | 6,413,000 | 2,984,000 | 1,841,000 |